CRISPR Therapeutics AG (CRSP)
Analyst consensus, price target and coverage. 18 analysts, updated daily.
Analyst votes
How the ratings break down
22 ratings on record
- Strong Buy4
- Buy9
- Hold9
- Underperform0
- Sell0
Price targets
Where the estimates sit
How far apart analysts are on this name.
Low 44.00
Mean 87.56
High 291.00
share price 53.99 mean target 87.56. Analysts are spread 561% apart.
Most recent action
Last rating change
| Firm | Citigroup |
|---|---|
| Date | 2026-08-04 |
| Change | Buy → Buy |
Size and liquidity
Key statistics
| Market cap | 5.22B USD |
|---|---|
| Cap class | Mid |
| Average volume | 1,668,304 |
| Dollar volume per day | 90.1M |
| Liquidity | High |
| Internal score | 84.1 / 100 |
Recommendation
How it moved, scan by scan
2 scans on record
| Scan | Move | Consensus | Score | SB | Buy | Hold | Und | Sell |
|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | = | Buy | 2.23 | 4 | 9 | 9 | 0 | 0 |
| 2026-08-11 | · | Buy | 2.23 | 4 | 9 | 9 | 0 | 0 |
Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. ▲ more positive, ▼ more negative, = unchanged.
History
Price target over time
2 daily points recorded
| Date | Price | Target | Upside | Consensus |
|---|---|---|---|---|
| 2026-08-13 | 53.99 | 87.56 | +62.2% | Buy |
| 2026-08-11 | 53.33 | 87.56 | +64.2% | Buy |
Similar coverage
Comparable mid-cap names
Closest upside among companies of the same size.